Schizophrenia; A Review on Promising Drug Delivery Systems

Bulbul E. O., Karantas I. D., Okur M. E., Siafaka P., Okur N. U.

CURRENT PHARMACEUTICAL DESIGN, vol.26, no.31, pp.3871-3883, 2020 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Review
  • Volume: 26 Issue: 31
  • Publication Date: 2020
  • Doi Number: 10.2174/1381612826666200523173102
  • Journal Name: CURRENT PHARMACEUTICAL DESIGN
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Agricultural & Environmental Science Database, BIOSIS, Biotechnology Research Abstracts, CAB Abstracts, Chemical Abstracts Core, EMBASE, MEDLINE, Veterinary Science Database
  • Page Numbers: pp.3871-3883
  • Istanbul University Affiliated: No

Abstract

Background: Schizophrenia belongs to mental illnesses affecting 1% of the worldwide population. Its therapy is still unmet; thus, researchers aimed to develop new pharmacological molecules which can improve its management.